Search Results - "Volny, O"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Optimizing fast first pass complete reperfusion in acute ischemic stroke - the BADDASS approach (BAlloon guiDe with large bore Distal Access catheter with dual aspiration with Stent-retriever as Standard approach) by Ospel, J M, Volny, O, Jayaraman, M, McTaggart, R, Goyal, M

    Published in Expert review of medical devices (02-11-2019)
    “…: Endovascular therapy is the standard of care for acute ischemic stroke due to large vessel occlusions. The ultimate goal is to achieve fast first pass…”
    Get more information
    Journal Article
  2. 2

    Displaying Multiphase CT Angiography Using a Time-Variant Color Map: Practical Considerations and Potential Applications in Patients with Acute Stroke by Ospel, J M, Volny, O, Qiu, W, Najm, M, Kashani, N, Goyal, M, Menon, B K

    Published in American journal of neuroradiology : AJNR (01-02-2020)
    “…Various imaging protocols exist for the identification of vessel occlusion and assessment of collateral flow in acute stroke. CT perfusion is particularly…”
    Get full text
    Journal Article
  3. 3

    Therapeutic plasma exchange in multiple sclerosis patients with an aggressive relapse: an observational analysis in a high-volume center by Bunganic, R., Blahutova, S., Revendova, K., Zapletalova, O., Hradilek, P., Hrdlickova, R., Ganesh, A., Cermakova, Z., Bar, M., Volny, O.

    Published in Scientific reports (01-11-2022)
    “…An evidence-based treatment for a Multiple Sclerosis (MS) relapse is an intravenous administration of 3–5 g of Methylprednisolone. In case of insufficient…”
    Get full text
    Journal Article
  4. 4

    Interrater Agreement and Detection Accuracy for Medium-Vessel Occlusions Using Single-Phase and Multiphase CT Angiography by Ospel, J M, Bala, F, McDonough, R V, Volny, O, Kashani, N, Qiu, W, Menon, B K, Goyal, M

    Published in American journal of neuroradiology : AJNR (01-01-2022)
    “…Accurate and reliable detection of medium-vessel occlusions is important to establish the diagnosis of acute ischemic stroke and initiate appropriate treatment…”
    Get full text
    Journal Article
  5. 5

    Serum neurofilament levels in patients with multiple sclerosis: A comparison of SIMOA and high sensitivity ELISA assays and contributing factors to ELISA levels by Revendova, K. Zondra, Zeman, D., Bunganic, R., Karasova, K., Volny, O., Bar, M., Kusnierova, P.

    Published in Multiple sclerosis and related disorders (01-11-2022)
    “…Serum neurofilaments (sNfs), especially the most investigated serum neurofilament light chain (sNfL), are promising biomarkers in multiple sclerosis (MS)…”
    Get full text
    Journal Article
  6. 6

    Neurofilament heavy chain and chitinase 3-like 1 as markers for monitoring therapeutic response in multiple sclerosis by Kusnierova, P., Revendova, K․Zondra, Karasova, K., Zeman, D., Bunganic, R., Hradilek, P., Volny, O., Ganesh, A., Kovacova, I., Stejskal, D.

    Published in Multiple sclerosis and related disorders (01-11-2024)
    “…•This article presents original data on the use of serum neurofilament heavy chain (sNfH) and chitinase 3-like 1 (CHI3L1) as a marker of therapeutic response…”
    Get full text
    Journal Article
  7. 7

    Permeability surface area product analysis in malignant brain edema prediction – A pilot study by Volny, O, Cimflova, P, Lee, T.-Y, Menon, B.K, d'Esterre, C.D

    Published in Journal of the neurological sciences (15-05-2017)
    “…Abstract Background and purpose Using an extended CT perfusion acquisition (150s), we sought to determine the association between perfusion parameters and…”
    Get full text
    Journal Article
  8. 8

    382P Decreased quality of life in Duchenne muscular disease patients related to functional neurological and cardiac impairment by Jurikova, L., Masarova, L., Panovsky, R., Pesl, M., Revendova, K. Zondra, Volny, O., Feithova, V., Holecek, T., Kincl, V., Danhofer, P., Vohanka, S., Haberlova, J., Podolska, K.

    Published in Neuromuscular disorders : NMD (01-10-2024)
    “…In this prospective study involving 37 Duchenne muscular dystrophy (DMD) patients aged 8–18 years and older, we examined the impact of neurological and cardiac…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11